Pharma, healthcare and biotech researchers constantly face pressure to keep up in a fast-paced and ever-evolving industry. The need to conduct high-risk clinical trials that require significant resources can make it even more challenging for small companies with limited financial and human resources to make go/no-go decisions.
A network of animal clinics and veterinary hospital can identify animals with spontaneous naturally occurring conditions that could benefit from new technologies, products, medications, therapies, and devices developed for both humans and animals.
Begun with an aim of improving the lives of animals with veterinary practices hosting clinical trials for patients with cancer, cognitive decline, organ disease (e.g., liver, heart, kidney), inflammation and immune-mediated, and low-incidence (MUMS) diseases.
People and pets share many of the same conditions, if a VHRC study finds a successful animal treatment, that data can have One Health translational value and will be very supportive in regulatory submissions for products treating people with the same condition.
The mission of VHRC has garnered support from prospective beneficiaries--researchers, veterinary practices, and pet owners--because benefits accrue to sponsors, veterinarians, and caregivers, all of whom are seeking viable treatment options for their patients and pets. This win-win-win design has enabled it to make a significant impact on the biotech industry.
VHRC was chosen us as a finalist for the 2023 Most Innovative Start-up Biotech Company by Citeline.